Concepedia

Wanqi Yang

WY

Statistics

Publications

35

Citations

1.9K

H-Index

19

Active since

2012

Affiliations

University of Electronic Science and Technology of China(Current)

Huzhou University

Heilongjiang Academy of Sciences

Harbin Medical University

Chinese Academy of Medical Sciences & Peking Union Medical College

Wanqi Yang is an author at University of Electronic Science and Technology of China specializing in life sciences, gene expression, and pharmacology.

ORCID

Publications per year

2012–2025

35

Publications

35

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu et al. · The Lancet Infectious Diseases · 2021 · 575 citations · Full text

, , +17

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han, Yufei Song, Changgui Li et al. · The Lancet Infectious Diseases · 2021 · 355 citations · Full text

, , +16

Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts

Tingting Li, Yuting Zhuang, Wanqi Yang et al. · The FASEB Journal · 2020 · 144 citations

, , +14

Enhanced uptake and transport of (+)-catechin and (-)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells

Qinxin Song, Danhui Li, Yongzhi Zhou et al. · International Journal of Nanomedicine · 2014 · 99 citations · Full text

, , +17

Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**

David Quach, Guanghui Tang, Jothi Anantharajan et al. · Angewandte Chemie International Edition · 2021 · 78 citations

, , +16

1–5 of 35